Mistral AI CEO: Nvidia partnership 'super meaningful' — Positive
NVDA CNBC International TV — June 13, 2025The partnership with Nvidia allows Mistral AI to "go faster and offer the best services," according to Mistral's Co-Founder and CEO Arthur Mensch, who spoke to CNBC at the VivaTech conference in Paris.

INVESTOR DEADLINE: Red Cat Holdings, Inc. (RCAT) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit — Neutral
RCAT GlobeNewsWire — June 13, 2025SAN DIEGO, June 13, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Red Cat Holdings, Inc. (NASDAQ: RCAT) securities between March 18, 2022 and January 15, 2025, both dates inclusive (the “Class Period”), have until Tuesday, July 22, 2025 to seek appointment as lead plaintiff of the Red Cat class action lawsuit. Captioned Olsen v. Red Cat Holdings, Inc., No. 25-cv-05427 (D.N.J.), the Red Cat class action lawsuit charges Red Cat and certain of Red Cat's top current and former executives with violations of the Securities Exchange Act of 1934.

Tesla raises price of refreshed Model S and Model X vehicles — Neutral
TSLA Proactive Investors — June 13, 2025Tesla Inc (NASDAQ:TSLA) has refreshed its flagship Model S and Model X vehicles in the US, with minor design and performance updates resulting in a $5,000 price increase across all trims. Prices for the Model S now start at $84,990 for the Long Range version and $99,990 for the high-performance Plaid.

OpenAI plans to continue working with Scale AI after rival Meta on Friday agreed to take a 49% stake in the artificial intelligence startup for $14.8 billion, OpenAI's CFO Sarah Friar told the VivaTech conference in Paris.

The Magnificent Seven stocks propelled the Nasdaq-100 Index (NDX) to a gain of 3.46% for the month ending June 12. And that gauge has risen by nearly 14% over the past 90 days.

Here's Why You Should Retain AMED Stock in Your Portfolio for Now — Positive
AMED Zacks Investment Research — June 13, 2025Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

Can CEG's Nuclear Power Keep Up With AI-Driven Data Center Demand? — Positive
CEG Zacks Investment Research — June 13, 2025CEG surges 43.2% in 3 months as it taps nuclear power to fuel rising AI data center demand with long-term deals.

Can Twilio's Cross-Sell Strategy Unlock Higher Profitability? — Positive
TWLO Zacks Investment Research — June 13, 2025Twilio aims to boost profit through cross-selling, with large customers rising 37% in the first quarter.

Great Lakes Stock Trading at a Discount: Is It Buy Time Now? — Positive
GLDD Zacks Investment Research — June 13, 2025Great Lakes Dredge & Dock Corporation's GLDD current valuation is enticing for investors. Currently, the stock is trading below its industry peers with a forward 12-month price-to-earnings (P/E) ratio of 12.43X, as evidenced by the chart below.

@ProsperTradingAcademy's Scott Bauer says Meta Platforms (META) is a stock to "buy the dip" on any pullback, saying it continues to build its position in A.I. META announced a $14.3B investment into Scale AI as Mark Zuckerberg aims to create a superintelligence lab.

Boeing (NYSE:BA) declined by 5% on Thursday, June 12, following the devastating crash of an Air India 787 Dreamliner, resulting in the death of 241 individuals. Although the 787 is generally regarded as a very safe aircraft, Boeing has encountered considerable scrutiny and penalties over the past year due to ongoing quality control problems, especially regarding its 737 MAX fleet.

Adobe (NASDAQ:ADBE) recently revealed its Q2 results (fiscal year ending in November), exceeding analyst expectations. The firm reported earnings of $5.06 per share on revenues of $5.9 billion, surpassing the consensus estimates of $4.97 per share and $5.8 billion, respectively.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR — Neutral
CAPR Accesswire — June 13, 2025NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Air Products to Showcase Industrial Gas Solutions at the PowderMet2025 International Conference on Powder Metallurgy and Particulate Materials — Neutral
APD PRNewsWire — June 13, 2025LEHIGH VALLEY, Pa. , June 13, 2025 /PRNewswire/ -- Air Products (NYSE:APD) will showcase industrial gas solutions and technologies for metals and materials processing applications at the PowderMet2025 International Conference on Powder Metallurgy and Particulate Materials from June 15-18 at the Sheraton Phoenix Downtown in Phoenix, Arizona.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED — Neutral
GMED Accesswire — June 13, 2025NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE:GMED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADTRAN Holdings, Inc. - ADTN — Neutral
ADTN Accesswire — June 13, 2025NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ADTRAN Holdings, Inc.("ADTRAN" or the "Company") (NASDAQ:ADTN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metallus Inc. - MTUS — Neutral
MTUS Accesswire — June 13, 2025NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Metallus Inc. ("Metallus" or the "Company") (NYSE:MTUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cable One, Inc. - CABO — Neutral
CABO Accesswire — June 13, 2025NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Cable One, Inc. ("Cable One" or the "Company") (NYSE:CABO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Enliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants — Neutral
ELVN PRNewsWire — June 13, 2025BOULDER, Colo. , June 13, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has priced its previously announced underwritten public offering of 8,394,737 shares of its common stock at a price to the public of $19.66 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase up to 1,780,263 shares of Enliven's common stock at a price to the public of $19.659 per pre-funded warrant, which represents the per share public …
